Hospitalization or Ambulatory Treatment of Acute Diverticulitis
- Conditions
- Diverticulitis
- Interventions
- Other: Ambulatory versus hospitalisation
- Registration Number
- NCT01081054
- Lead Sponsor
- Hospital Universitari de Bellvitge
- Brief Summary
The purpose of 01DIVER is to evaluate efficacy and safety of a home treatment protocol for non complicated diverticulitis compared with management in the hospital. The hypothesis is that a ambulatory treatment with oral antibiotic and progressive introduction of diet is not inferior to the conservative management in hospital in patients with acute not complicated sigmoid diverticulitis, shown by contrast enhanced CT scan. Patients are prospectively randomized to conservative antibiotic treatment either to ambulatory or to hospital treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 132
- Age older than 18 years
- Diagnosis of mild diverticulitis by abdominal computerized tomography
- Signed informed consent
- Severe diverticulitis
- Informed consent not signed
- Suspicion of colon cancer
- Pneumoperitoneum
- Intolerance for oral feeding
- Antibiotics for diverticulitis in the last month
- Immunosuppression
- Pregnancy or lactation
- Severe (decompensated) other illness
- Psychological or social problems
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ambulatory Treatment Ambulatory versus hospitalisation Patients are treated ambulatory with oral antibiotic for 10 days; for the first five days these patients are contacted by telephone daily to progress oral intake. Hospital treatment Ambulatory versus hospitalisation Patients are hospitalized and treated with antibiotic, for the first days by endovenous antibiotic and with diet progression orally.
- Primary Outcome Measures
Name Time Method Treatment failure 30 days Failure of the conservative treatment within 30 days after randomization which consists in one or more of the mentioned signs: persistent or increasing pain, treatment resistant fever, intestinal oclusion, necesity to drain a new intra-abdominal abscess, indication for surgery, mortality.
- Secondary Outcome Measures
Name Time Method Recurrence, quality of life, costs 30 days Recurrence of diverticulitis within 30 days; quality of life and patient satisfaction is asessed comparing management with and without admittance to the hospital and costs are calculated for the treatment in both regimens.
Trial Locations
- Locations (5)
Hospital Universitari Bellvitge, Colorectal Unit
🇪🇸L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Virgen del Camino
🇪🇸Pamplona, Navarra, Spain
Hospital Universitari de la Vall d´Hebron
🇪🇸Barcelona, Spain
Hospital Universitari de Girona Doctor Josep Trueta
🇪🇸Girona, Spain
Hospital Clinico Universitario De Valencia
🇪🇸Valencia, Spain
Hospital Universitari Bellvitge, Colorectal Unit🇪🇸L'Hospitalet de Llobregat, Barcelona, Spain